Articles, guides, and regulatory updates from our community.
New computational research explores carbonless analogues of GHK peptide, suggesting stronger copper binding and broader conformational flexibility. Learn what this means.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 may protect against heart damage from chemotherapy drugs through H2O2 regulation mechanisms.
By Peptide Association Research Team
Groundbreaking 2026 study uncovers how mitochondrial dysfunction drives inflammation and cell death in type 2 diabetes, pointing to new treatment paths.
By Peptide Association Research Team
New research examines safety profiles of approved and unapproved peptide therapies for sports medicine, revealing gaps in human safety data for popular compounds.
By Peptide Association Research Team
New research on SS-31 peptide-loaded liposomes suggests potential for targeting mitochondrial function in fat cells. Study shows promising results in animal models.
By Peptide Association Research Team
Recent research explores mitochondrial-targeted liposomes containing SS-31 peptide for obesity treatment. Study shows improved fat metabolism in animal models.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 could help prevent heart damage from cancer treatment. Learn about this promising research.
By Peptide Association Research Team
Comprehensive study examines approved and unapproved peptides for musculoskeletal injuries. Learn about safety profiles and regulatory status.
By Peptide Association Research Team
Recent 2026 study shows SS-31 peptide in targeted liposomes may improve mitochondrial function in fat cells. Animal research suggests potential for obesity treatment.
By Peptide Association Research Team
New research explores how the mitochondria-targeted antioxidant peptide SS-31 may help protect cardiac function in laboratory studies of doxorubicin toxicity.
By Peptide Association Research Team
New research reveals how repurposing existing drugs could offer faster, safer therapeutic options for Alzheimer's disease treatment and prevention.
By Peptide Association Research Team
Breakthrough study reveals how SS-31 peptide and targeted liposomes may enhance fat burning by improving mitochondrial function in adipose tissue.
By Peptide Association Research Team
New research examines approved vs unapproved peptides for musculoskeletal injuries. Study reveals safety gaps in gray market compounds lacking oversight.
By Peptide Association Research Team
New research from 34 countries shows how physical and social environments accelerate brain aging by up to 9-fold, affecting 18,701 participants.
By Peptide Association Research Team
New research reveals how existing medications could be repurposed for Alzheimer's treatment, offering hope beyond traditional therapies with known safety profiles.
By Peptide Association Research Team
New research on mitochondria-targeted liposomes with SS-31 peptide demonstrates potential for enhancing thermogenesis in adipose tissue studies.
By Peptide Association Research Team
New research on carbonless amino acids reveals modified GHK peptides may have stronger metal binding properties. Study findings and clinical implications.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs. unapproved peptide therapies for musculoskeletal injuries and athletic performance.
By Peptide Association Research Team
Systematic review of 142 studies reveals newer antidiabetic drugs are generally cost-effective, though access varies by income level and drug pricing.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs unapproved peptide therapies for injury recovery and performance enhancement.
By Peptide Association Research Team
Systematic review of 142 studies reveals newer diabetes drugs show cost-effectiveness, but affordability varies by country income levels and treatment timing.
By Peptide Association Research Team
New research reveals how existing drugs like metformin and GLP-1 agonists may offer alternative approaches to Alzheimer's treatment through repurposing strategies.
By Peptide Association Research Team
Research reveals how mitochondria-targeted liposomes enhance thermogenesis in fat cells, offering potential obesity treatment through improved cellular metabolism.
By Peptide Association Research Team
New research reveals how existing medications could be repurposed for Alzheimer's disease treatment, offering hope beyond current limited therapies.
By Peptide Association Research Team